- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 7/06 - Antianaemics
Patent holdings for IPC class A61P 7/06
Total number of patents in this class: 1791
10-year publication summary
|
60
|
114
|
102
|
129
|
161
|
182
|
138
|
151
|
101
|
86
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Acceleron Pharma Inc. | 340 |
38 |
| Agios Pharmaceuticals, Inc | 224 |
38 |
| Global Blood Therapeutics, Inc. | 169 |
26 |
| Daiichi Sankyo Company, Limited | 1890 |
24 |
| Keros Therapeutics, Inc. | 81 |
20 |
| The Children's Hospital of Philadelphia | 857 |
19 |
| Vifor (International) AG | 145 |
19 |
| Children's Medical Center Corporation | 1959 |
17 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3229 |
16 |
| Novartis AG | 10262 |
14 |
| Assistance Publique-hopitaux de Paris (aphp) | 568 |
14 |
| Pharmacosmos Holding A/S | 202 |
14 |
| Akebia Therapeutics, Inc. | 125 |
13 |
| Université Paris Cité | 904 |
13 |
| Takeda Pharmaceutical Company Limited | 2712 |
12 |
| Sunshine Lake Pharma Co., Ltd. | 626 |
11 |
| Disc Medicine, Inc. | 94 |
11 |
| Société des Produits Nestlé S.A. | 10108 |
10 |
| The Regents of the University of California | 20745 |
10 |
| Epizyme, Inc. | 360 |
10 |
| Other owners | 1442 |